medical cannabis
medical cannabis · page 37
- Medical
Tikun receives licence to begin operations in Greek facility
The approval follows the successful completion of its 56,000m2 state-of-the-art production site in Corinth, Greece.
- Medical
Positive results for phase 2 clinical trial on cannabis-based sleep apnoea treatment
The FDA’s interest in the treatment as a potential therapy for sleep apnoea is “extremely encouraging”.
- Medical
International medical cannabis conference to take place in Lisbon next week
Cannabis is known to help children with autism, cancer and epilepsy. Doctors will explain how next week in Lisbon, Portugal.
- Companies
VIVO Cannabis announces findings from clinical study on anxiety and depression
The study provides evidence to support the effectiveness of medical cannabis as a treatment for anxiety and depression.
- Companies
Lyphe Group launches new medical cannabis clinic in Guernsey
The organisation is aiming to support the expanding patient community with the clinic’s opening.
- Medical
Phase II trial for potential cannabis dementia treatment completed
MGC Pharma has carried out a clinical trial with its Cognican formula – an oral spray containing THC and CBD.
- Companies
Khiron to acquire German pharmaceutical manufacturer and wholesaler
The global medical cannabis company is set to acquire Pharmadrug GmbH from its parent company, PharmaDrug Inc.
- Companies
Global medical cannabis market to reach £42.17bn by 2027
The global market is likely to rise at a CAGR of 26.6 per cent from 2019 to 2027.
- Companies
UK’s Lyphe Group secures £5m funding to expand into Europe
The funding round was led by Europe’s first cannabis and psychedelics fund, Leafy Tunnel.
- Medical
Patient’s cannabis case sets new precedent in UK court
A cannabis patient will not face a prison sentence after receiving legal support from Cancard.
- Medical
Panaxia to begin medical cannabis production in Malta
The company has announced that it has obtained a production license for medical cannabis products in the country.
- CBD Market
Tetra Bio-Pharma receives European orphan drug designation for novel CBD cream
The CBD-containing topical preparation has received Orphan Drug Designation from the European Medicines Agency (EMA).
